Search

everythinglearnresearchcommunity

for

Search:↓

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Hair shedding is an active process that could be targeted to treat hair loss.

EPR spectroscopy showed that spontaneous hair growth results in thicker skin and less pigmented hair than depilation-induced growth.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Wnt10b overexpression can regenerate hair follicles, possibly helping treat hair loss and alopecia.

Ginsenoside F2 from ginseng may increase hair growth better than standard treatments by affecting cell growth signals.

MicroRNAs play a key role in wool growth in Tibetan sheep.

BMP6 and Wnt10b control whether hair follicles are resting or growing.

GasderminA3 is important for normal hair cycle transitions by controlling Wnt signaling.

Increasing Wnt5a in mice skin delays hair growth but doesn't stop it.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

A man lost a lot of scalp hair quickly after stopping minoxidil, but it grew back with mild male pattern baldness.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Gamma-rays exposure during the resting phase of hair growth can damage hair regeneration and color in mice.

Thymosin β4 helps increase hair growth in Cashmere goats.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

GV-350 improves hair growth and quality of life in iron-deficient women without side effects.